A Novel Method for Detection and ex Vivo Expansion of HIV Type 1-Specific Cytolytic T Lymphocytes

AIDS Research and Human Retroviruses

Volumn 10, Issue 11, 1994, Pages 1427-1431

  Lubaki, M N ^a   Egan, M A ^a   Siliciano, R F ^a   Weinhold, K J ^b   Bollinger, R C ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CELL SPECIFICITY; CELLULAR IMMUNITY; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOBLASTOID CELL LINE; LYMPHOCYTE ACTIVATION; LYMPHOCYTOTOXICITY; PRIORITY JOURNAL; TECHNIQUE;

CELL SEPARATION; CYTOTOXICITY, IMMUNOLOGIC; GENE PRODUCTS, ENV; GENE PRODUCTS, GAG; GENE PRODUCTS, NEF; GENETIC VECTORS; HIV INFECTIONS; HIV-1; HUMAN; IN VITRO; LYMPHOCYTE ACTIVATION; SUPPORT, U.S. GOV'T, P.H.S.; T-LYMPHOCYTES, CYTOTOXIC; VACCINIA VIRUS; VIREMIA;

EID: 0028170747     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.1994.10.1427     Document Type: Article

References (24)

1. Lin YL and Askonas BA: Biological properties of an influenza A virus-specific killer T cell clone. Inhibition of virus replication in vivo and induction of delayed-type hypersensitivity reactions. J Exp Med 1981; 154: 225–234.
2. Lukacher AE, Braciale VL, and Braciale TJ: In vivo effector function of influenza virus-specific cytotoxic T lymphocyte clones is highly specific. J Exp Med 1984; 160: 814–826.
3. Byrne JA and Oldstone MBA: Biology of cloned cytotoxic T for lymphocytes specific for lymphocytic choriomeningitis virus: Clearance of virus in vivo. J Virol 1984; 51: 682–686.
4. Walker BD, Chakrabarti S, Moss B, Paradis TJ, Flynn T, Durno AG, Blumberg RS, Kaplan JC, Hirsch MS, and Schooley RT: HIV specific cytotoxic T lymphocytes in seropositive individuals. Nature (London) 1987; 328: 345–348.
5. Koenig S, Earl P, Powell D, Pantaleo G, Merli S, Moss B, and Fauci AS: Group-specific, major histocompatibility complex class I-restricted cytotoxic responses to human immunodeficiency virus 1 (HIV-1) envelope proteins by cloned peripheral blood T cells from an HIV-1-infected individual. Proc Nad Acad Sci USA 1988; 85: 8638–8642.
6. + cytolytic T lymphocytes isolated from seronegative humans immunized with candidate HIV-1 vaccines. J Exp Med 1992; 176: 1531–1542.
7. + human cytolytic T cells specific for HIV-infected cells by a gpl60 subunit vaccine. Science 1990; 248: 1234–1237.
8. + cytotoxic T-lymphocyte clone to a conserved epitope on human immunodeficiency virus type 1 p24: cytotoxic activity and secretion of interleukin-6. J Virol 1992; 66: 608–611.
9. + human immunodeficiency virus type 1 (HIV-1) envelopespecific cytotoxic T lymphocytes derived from the peripheral blood cells of an HIV-1-infected individual. AIDS Res Hum Retroviruses 1993; 9(1):61–68.
10. + T cell recognition. J Exp Med 1990; 171: 875–887.
11. Meuer SC, Schlossman SF, and Reinherz EL: Clonal analysis of human cytotoxic T lymphocytes: T4+ and T8+ effector cells recognize products of different major histocompatibility complex regions. Proc Nati Acad Sci USA 1982; 79: 4395–4399.
12. Watson AJ, Klaniecki J, and Hanson CV: Psoralen/UV inactivation of HIV-1 infected cells for use in cytologie and immunologie procedures. AIDS Res Hum Retroviruses 1990; 6: 503–513.
13. Hanson CV, Riggs JL, and Lennette EH: Photochemical inactivation of DNA and RNA viruses by psoralen derivatives. J Gen Virol 1978; 40(2):345–348.
14. Redfield DC, Richman DD, Oxman MN, and Kronenberg LH: Psoralen inactivation of influenza and herpes simplex viruses and of virus-infected cells. Infect Immun 1981;32(3): 1216–1226.
15. + T lymphocytes of patients with AIDS maintain normal broad cytolytic function despite the loss of human immunodeficiency virus-specific cytotoxicity. Immunology 1990; 87: 4818–4822.
16. Koenig S, Earl P, Powell D, Pantelo G, Merli S, Moss B, and Fauci A: Group-specific, major histocompatibility complex class I-restricted cytotoxic responses to human immunodeficiency virus 1 (HIV-1) envelope proteins by cloned peripheral blood T cells from an HIV-1 infected individual. Immunology 1988; 85: 8638–8642.
17. Grant MD, Smaill FM, Singal DP, and Rosenthal KL: The influence of lymphocytes counts and disease progression on circulating and inducible anti-HIV-1 cytotoxic T-cell activity in HIV-1-infected subjects. AIDS 1992; 6: 1085–1093.
18. Rowland-Jones SL, Nixon DF, Aldhous MC, Gotch F, Ariyoshi K, Hallam N, Kroll JS, Froebel K, and McMichael A: HIV-specific cytotoxic T cell activity in an HIV-exposed but uninfected infant. Lancet 1993; 341: 860–861.
19. Hoffenbach A, Plat etal.: Unusually high frequencies of HTV-specific cytolytic T lymphocytes in humans. J Immun 1989; 142(2):452–462.
20. Connick E, Clark S, Saag MS, Schooley RT, and Curiel TJ: HIV specific cellular immunity in primary HIV-1 infection. Int Conf AIDS Jun 6-11, 1993; 9(1):216 (Abstract No. PO-A22-0488).
21. + T cells: Cytotoxic T-lymphocyte epitopes and precursor frequencies. AIDS 1993; 7(6):781–786.
22. Lieberman J, Shanker P, Fabry J, and Skolnik PR. Ex vivo expansion of HIV-1 specific cytotoxic T lymphocytes. 8th Inter Conf Immun 1992, Budapest, Hungary.
23. Lieberman J, Fabry JA, Kuo M-C, Earl P, Moss B, and Skolnik PR: Cytotoxic T lymphocytes from HIV-1 seropositive individuals recognize immunodominant epitopes in gpl60 and reverse transcriptase. J Immunol 1992; 148: 2738–2747.
24. Lieberman J, Fabry JA, Beckett L, and Skolnik P: Ex vivo expansion of HIV-1 specific cytolytic T cells from HIV-1 seronegative subjects. AIDS Res Hum Retroviruses 1994 (in press).